• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  05/30/2013
Trade Name:  Kepivance
Generic Name or Proper Name (*):  palifermin
Indications Studied:  Acute leukemias undergoing myeloablative therapy and allogeneic hematopoietic stem cell transplant
Label Changes Summary:  * Use in pediatric patients ages 1 - 16 years is supported by evidence from adequate and well-controlled studies in adults and a phase 1 study that included 27 pediatric patients with acute leukemia undergoing hematopoietic stem cell transplant * Postmarketing study
Product Labeling:  Labeling  Opens a new window
Sponsor:  Quintiles, Inc.
Therapeutic Category:  Immunologic agent